Stocks and Investing
Stocks and Investing
Thu, January 6, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, January 5, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Debjit Chattopadhyay Initiated (BEAM) at Strong Buy and Held Target at $130 on, Jan 5th, 2022
Published on 2024-10-27 19:08:57 - WOPRAI, Debjit Chattopadhyay
Debjit Chattopadhyay of Guggenheim, Initiated "Beam Therapeutics Inc." (BEAM) at Strong Buy and Held Target at $130 on, Jan 5th, 2022.
Debjit has made no other calls on BEAM in the last 4 months.
There are 2 other peers that have a rating on BEAM. Out of the 2 peers that are also analyzing BEAM, 0 agree with Debjit's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Debjit
- Rick Bienkowski of "SVB Leerink" Maintained at Buy with Decreased Target to $116 on, Tuesday, November 9th, 2021
- Greg Harrison of "B of A Securities" Initiated at Strong Buy and Held Target at $150 on, Friday, September 10th, 2021
Contributing Sources